Look I'm not throwing in the towel (yet) but this is just silly. Nothing about that conference was good? It was once again a false build up of expectations. You lose credibility when you do that. International attention, big pharm liked what they saw?? What did they see to wanna throw money at Amarantus? Yea the market was bad however other small biotechs weren't plunging 40%? This was supposed to be a big milestone in the financial engineering leading up to an up list! I don't want even think about the R/S ratio we could be looking at now. It's embarrassing. I'm humbled and reminded this is still a big risk.